Evidence map›Paper›PMID 36671436›Full record

ArticleBiomolecules2022

Age- and Sex-Dependent Behavioral and Neurochemical Alterations in hLRRK2-G2019S BAC Mice.

Ning Yao, Olga Skiteva, Karima Chergui

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ning YaoMolecular Neurophysiology Laboratory, Department of Physiology and Pharmacology, Karolinska Institutet, 171 64 Stockholm, Sweden.ORCID 0000-0001-8090-5915
Olga SkitevaMolecular Neurophysiology Laboratory, Department of Physiology and Pharmacology, Karolinska Institutet, 171 64 Stockholm, Sweden.
Karima CherguiMolecular Neurophysiology Laboratory, Department of Physiology and Pharmacology, Karolinska Institutet, 171 64 Stockholm, Sweden.ORCID 0000-0001-5702-0422
Karolinska Institutet · SE

Funding

Åhlén-Stiftelsen 213014Parkinsonfonden 1325/21Swedish Research Council 2018-02979
6 · The paper itself

Abstract

The G2019S mutation in the leucine-rich repeat kinase 2 (

Indexed as

Protein Serine-Threonine KinasesSubstantia NigraAnimalsCorpus StriatumFemaleLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MaleMiceMice, TransgenicMutationLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanProtein Serine-Threonine KinasesBAC: bacterial artificial chromosomeDA: dopaminergicDAT: dopamine transporterKI: knock-inLRRK2: leucine-rich repeat kinase 2PD: Parkinson’s diseaseSNc: substantia nigra pars compactaTH: tyrosine hydroxylase

Identifiers

PMID36671436
PMCPMC9856037
OpenAlexW4313415281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.